Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-030-02771-1_6PMID 30623367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

  2023cited by this paper
• CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer

  2018cited by this paper
• Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.

  2018cited by this paper
• Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy

  2018cited by this paper
• Cell-type specific potent Wnt signaling blockade by bispecific antibody

  2018cited by this paper
• Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models

  2018cited by this paper
• The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine

  2018cited by this paper
• Colorectal Cancers: An Update on Their Molecular Pathology

  2018cited by this paper
• Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.

  2018cited by this paper
• The Role of Curcumin in Prevention and Management of Metastatic Disease

  2018cited by this paper
• The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies

  2018cited by this paper
• Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells

  2018cited by this paper
• Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer

  2018cited by this paper
• Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action

  2018cited by this paper
• Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications

  2017cited by this paper
• Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

  2017cited by this paper
• Wnt/beta-catenin pathway: modulating anticancer immune response

  2017cited by this paper
• New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds

  2017cited by this paper
• Pertuzumab + trastuzumab for HER2-amplified/overexpressed metastatic colorectal cancer (mCRC): Interim data from MyPathway.

  2017cited by this paper
• Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling

  2017cited by this paper
• Optimizing the use of anti VEGF targeted therapies in patients with metastatic colorectal cancer: review of literature

  2017cited by this paper
• Chasing the personalized medicine dream through biomarker validation in colorectal cancer.

  2017cited by this paper
• Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

  2017cited by this paper
• Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.

  2017cited by this paper
• (−)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway

  2017cited by this paper
• Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a

  2017cited by this paper
• Friend or foe? The tumour microenvironment dilemma in colorectal cancer.

  2017cited by this paper
• University of Birmingham KRAS mutation and Consensus Molecular Subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer

  2017cited by this paper
• Chitosan-Coated Cinnamon/Oregano-Loaded Solid Lipid Nanoparticles to Augment 5-Fluorouracil Cytotoxicity for Colorectal Cancer: Extract Standardization, Nanoparticle Optimization, and Cytotoxicity Evaluation.

  2017cited by this paper
• Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

  2017cited by this paper
• APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer

  2017cited by this paper
• Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

  2017cited by this paper
• Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study

  2017cited by this paper
• A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo

  2017cited by this paper
• GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.

  2017cited by this paper
• Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

  2017cited by this paper
• The combination of curcumin and 5-fluorouracil in cancer therapy

  2017cited by this paper
• Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling

  2017cited by this paper
• Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells

  2017cited by this paper
• FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway

  2017cited by this paper
• Neoadjuvant chemotherapy affects molecular classification of colorectal tumors

  2017cited by this paper
• Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases

  2017cited by this paper
• Regulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding

  2017cited by this paper
• Immunological landscape of consensus clusters in colorectal cancer

  2017cited by this paper
• EGFR gene copy number predicts response to anti‐EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer

  2017cited by this paper
• Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions

  2017cited by this paper
• Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers

  2017cited by this paper
• Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling

  2016cited by this paper
• Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway.

  2016cited by this paper
• Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer

  2016cited by this paper
• Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis

  2016cited by this paper
• The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase

  2016cited by this paper
• TNIK inhibition abrogates colorectal cancer stemness

  2016cited by this paper
• Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1

  2016cited by this paper
• Wnt signaling in cancer

  2016cited by this paper
• Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway

  2016cited by this paper
• Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer

  2016cited by this paper
• Black raspberries in cancer clinical trials: Past, present and future

  2016cited by this paper
• Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

  2016cited by this paper
• Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.

  2016cited by this paper
• Mechanisms of resistance to anti-EGFR therapy in colorectal cancer

  2016cited by this paper
• Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors

  2016cited by this paper
• A Promising Road in Colorectal Cancer Treatment: Personalized Immunotherapy Based on Molecular and Immune Classification System

  2016cited by this paper
• The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2*

  2016cited by this paper
• Effect of Citrus Bioactive Compounds on Targeting Human Colorectal Cancer Stem Cells

  2016cited by this paper
• Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.

  2016cited by this paper
• Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer

  2016cited by this paper
• Frizzled7: A Promising Achilles’ Heel for Targeting the Wnt Receptor Complex to Treat Cancer

  2016cited by this paper
• Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.

  2016cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer

  2016cited by this paper
• ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

  2016cited by this paper
• Wnt pathway regulation of intestinal stem cells

  2016cited by this paper
• Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth

  2016cited by this paper
• Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells

  2016cited by this paper
• Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

  2016cited by this paper
• Dietary components as epigenetic-regulating agents against cancer

  2016cited by this paper
• Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta

  2016cited by this paper
• Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

  2016cited by this paper
• A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.

  2016cited by this paper
• The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance

  2016cited by this paper
• HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma

  2016cited by this paper
• Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.

  2016cited by this paper
• Resveratrol, in its natural combination in whole grape, for health promotion and disease management

  2015cited by this paper
• A new paradigm for tumor immune escape: β-catenin-driven immune exclusion

  2015cited by this paper
• HER2 activating mutations are targets for colorectal cancer treatment.

  2015cited by this paper
• Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.

  2015cited by this paper
• Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer

  2015cited by this paper
• The Consensus Molecular Subtypes of Colorectal Cancer

  2015cited by this paper
• Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.

  2015cited by this paper
• Immune checkpoints and immunotherapy for colorectal cancer

  2015cited by this paper
• Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial

  2015cited by this paper
• Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.

  2015cited by this paper
• Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

  2015cited by this paper
• The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment.

  2015cited by this paper
• Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer

  2015cited by this paper
• Prospective derivation of a living organoid biobank of colorectal cancer patients.

  2015cited by this paper
• β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10

  2015cited by this paper
• Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes

  2015cited by this paper
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

  2015cited by this paper

• High-Resolution Spatial Proteomics Characterises Colorectal Cancer Consensus Molecular Subtypes

  2025cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• From Subtypes to Solutions: Integrating CMS Classification with Precision Therapeutics in Colorectal Cancer

  2024cites this paper
• Charting the Heterogeneity of Colorectal Cancer Consensus Molecular Subtypes using Spatial Transcriptomics

  2023cites this paper
• Small-molecule drugs of colorectal cancer: Current status and future directions.

  2023cites this paper
• Recovering false negatives in CRISPR fitness screens with JLOE

  2022cites this paper
• 188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells

  2022cites this paper
• Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

  2021cites this paper
• Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell

  2021influential citation
• Biases and Blind-Spots in Genome-Wide CRISPR Knockout Screens

  2020cites this paper
• Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma

  2019cites this paper